Baldwin Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Baldwin Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,000	Closed	-$243K	–	209
2024 Q4	$243K	Sell	2,000 -250	-11%	-$30.6K	0.03%	188
2024 Q3	$281K	Hold	2,250	–	–	0.04%	186
2024 Q2	$356K	Hold	2,250	–	–	0.05%	167
2024 Q1	$291K	Sell	2,250 -50	-2%	-$6.13K	0.04%	186
2023 Q4	$222K	Hold	2,300	–	–	0.03%	196
2023 Q3	$279K	Hold	2,300	–	–	0.05%	169
2023 Q2	$263K	Hold	2,300	–	–	0.04%	176
2023 Q1	$317K	Hold	2,300	–	–	0.06%	169
2022 Q4	$298K	Hold	2,300	–	–	0.05%	173
2022 Q3	$254	Buy	+2,300	New	+$232K	0.05%	183
2022 Q1	–	Sell	-2,300	Closed	-$207	–	258
2021 Q4	$207	Hold	2,300	–	–	0.03%	244
2021 Q3	$213K	Buy	+2,300	New	+$177K	0.04%	236
2021 Q1	–	Sell	-2,300	Closed	-$392K	–	252
2020 Q4	$392K	Hold	2,300	–	–	0.08%	163
2020 Q3	$323K	Sell	2,300 -500	-18%	-$76K	0.08%	157
2020 Q2	$449K	Hold	2,800	–	–	0.14%	101
2020 Q1	$274K	Sell	2,800 -400	-13%	-$45.7K	0.09%	121
2019 Q4	$413K	Sell	3,200 -100	-3%	-$10.1K	0.11%	123
2019 Q3	$249K	Hold	3,300	–	–	0.07%	146
2019 Q2	$501K	Hold	3,300	–	–	0.14%	107
2019 Q1	$393K	Hold	3,300	–	–	0.12%	118
2018 Q4	$360K	Hold	3,300	–	–	0.11%	114
2018 Q3	$533K	Hold	3,300	–	–	0.15%	99
2018 Q2	$436K	Buy	+3,300	New	+$311K	0.14%	110

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Baldwin Investment Management's SRPT Position: Q1 2025 in Review

Baldwin Investment Management sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,000 shares — an estimated $243K sold.

Baldwin Investment Management first reported a position in SRPT in Q2 2018 and held it in 23 quarters. The position peaked at $533K in Q3 2018. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

Baldwin Investment Management reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
Baldwin Investment Management sold 2,000 Sarepta Therapeutics shares in Q1 2025, an estimated $243K.
Baldwin Investment Management first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 23 quarters.
Baldwin Investment Management's Sarepta Therapeutics position peaked at $533K in Q3 2018.
430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Baldwin Investment Management's 13F filing for Q1 2025, filed 7 May 2025.